Switching to burosumab from conventional therapy in siblings with relatively well-controlled X-linked hypophosphatemia.

Senoo, Shintaro; Fujimoto, Masanobu; Yamaguchi, Yukiko; Osaki, Mari; Hanaki, Keiichi; Namba, Noriyuki.

Afiliação

Senoo S; Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Yonago, Japan.
Fujimoto M; Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Yonago, Japan.
Yamaguchi Y; Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Yonago, Japan.
Osaki M; Rehabilitation Division, Tottori University Hospital, Yonago, Japan.
Hanaki K; School of Health Science, Faculty of Medicine, Tottori University, Yonago, Japan.
Namba N; Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Yonago, Japan.

Clin Pediatr Endocrinol ; 33(1): 27-34, 2024.

Article em En | MEDLINE | ID: mdl-38299174